Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Page 1
One-Year Health Status Outcomes Following Early Invasive and Noninvasive Treatment in Symptomatic Peripheral Artery Disease.
Angraal S, Hejjaji V, Tang Y, Gosch KL, Patel MR, Heyligers J, White CJ, Tutein Nolthenius R, Mena-Hurtado C, Aronow HD, Moneta GL, Fitridge R, Soukas PA, Abbott JD, Secemsky EA, Spertus JA, Smolderen KG. Angraal S, et al. Among authors: abbott jd. Circ Cardiovasc Interv. 2022 Jun;15(6):e011506. doi: 10.1161/CIRCINTERVENTIONS.121.011506. Epub 2022 May 17. Circ Cardiovasc Interv. 2022. PMID: 35579010 Free article.
Over 1 year of follow-up, patients who underwent early invasive management reported significantly higher health status than patients managed noninvasively (interaction term for time and treatment strategy; P<0.001 for all Peripheral Artery Questionnaire domains). ...
Over 1 year of follow-up, patients who underwent early invasive management reported significantly higher health status than patients managed …
Dual antiplatelet therapy duration after percutaneous coronary intervention using drug eluting stents in high bleeding risk patients: A systematic review and meta-analysis.
Garg A, Rout A, Farhan S, Waxman S, Giustino G, Tayal R, Abbott JD, Huber K, Angiolillo DJ, Rao SV. Garg A, et al. Among authors: abbott jd. Am Heart J. 2022 Aug;250:1-10. doi: 10.1016/j.ahj.2022.04.004. Epub 2022 Apr 15. Am Heart J. 2022. PMID: 35436504
BACKGROUND: Optimal dual antiplatelet therapy (DAPT) duration in patients at high bleeding risk (HBR) is not fully defined. We aimed to compare the safety and effectiveness of short-term DAPT (S-DAPT) with longer duration DAPT (L-DAPT) after percutaneous coronary intervent …
BACKGROUND: Optimal dual antiplatelet therapy (DAPT) duration in patients at high bleeding risk (HBR) is not fully defined. We aimed to comp …
Meta-Analysis Comparing Outcomes With Bifurcation Percutaneous Coronary Intervention Techniques.
Elbadawi A, Shnoda M, Dang A, Gad M, Abdelazeem M, Saad M, Salama A, Sharma A, Gilani S, Latib A, Rab T, Elgendy IY, Abbott JD. Elbadawi A, et al. Among authors: abbott jd. Am J Cardiol. 2022 Feb 15;165:37-45. doi: 10.1016/j.amjcard.2021.10.048. Epub 2021 Dec 20. Am J Cardiol. 2022. PMID: 34937656
In this meta-analysis of randomized trials, we found no difference between 1-stent versus 2-stent bifurcation percutaneous coronary intervention approaches in the risk of MACE during long-term follow-up. Among the various bifurcation techniques, double kissing crush techni …
In this meta-analysis of randomized trials, we found no difference between 1-stent versus 2-stent bifurcation percutaneous coronary interven …
Relation of abnormal cardiac stress testing with outcomes in patients undergoing renal transplantation.
Anderson K, Bavishi C, Kolte D, Gohh R, Arrighi JA, Stockwell P, Abbott JD. Anderson K, et al. Among authors: abbott jd. PLoS One. 2021 Dec 2;16(12):e0260718. doi: 10.1371/journal.pone.0260718. eCollection 2021. PLoS One. 2021. PMID: 34855868 Free PMC article.
In our cohort, 9 patients (3.9%) had MACE at 30-days post-transplant, 5 of whom had an abnormal stress test. The long-term MACE rate, at a median of 5 years, was 32%. After adjustment, diabetes (OR 2.37, 95% CI 1.12-5.00, p = 0.02), CAD (OR: 3.05, 95% CI 1.30-7.14, p = 0.0 …
In our cohort, 9 patients (3.9%) had MACE at 30-days post-transplant, 5 of whom had an abnormal stress test. The long-term MACE rate, …
Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
Latif A, Ahsan MJ, Lateef N, Aurit S, Mirza MM, Siller-Matula JM, Mamas MA, Parikh M, Brilakis ES, Abbott JD, Bhatt DL, Velagapudi P. Latif A, et al. Among authors: abbott jd. Catheter Cardiovasc Interv. 2022 Feb;99(2):254-262. doi: 10.1002/ccd.30017. Epub 2021 Nov 12. Catheter Cardiovasc Interv. 2022. PMID: 34767299
There was no statistical difference in in-hospital (RR = 1.50; 95% CI: 0.73 to 3.09) or longer term (6 months) all-cause mortality (RR = 1.10; 95% CI: 0.86 to 1.42) between the two groups. ...
There was no statistical difference in in-hospital (RR = 1.50; 95% CI: 0.73 to 3.09) or longer term (6 months) all-cause mortality (R …
Outcomes With Drug-Coated Balloons vs. Drug-Eluting Stents in Small-Vessel Coronary Artery Disease.
Megaly M, Buda K, Saad M, Tawadros M, Elbadawi A, Basir M, Abbott JD, Rinfret S, Alaswad K, Brilakis ES. Megaly M, et al. Among authors: abbott jd. Cardiovasc Revasc Med. 2022 Feb;35:76-82. doi: 10.1016/j.carrev.2021.03.008. Epub 2021 Mar 20. Cardiovasc Revasc Med. 2022. PMID: 33858783
DCB appears as an attractive alternative to DES in patients with de-novo SVD, but long-term clinical data are still needed....
DCB appears as an attractive alternative to DES in patients with de-novo SVD, but long-term clinical data are still needed....
Systematic review and meta-analysis of short-term outcomes with drug-coated balloons vs. stenting in acute myocardial infarction.
Megaly M, Buda KG, Xenogiannis I, Vemmou E, Nikolakopoulos I, Saad M, Rinfret S, Abbott JD, Aronow HD, Garcia S, Pershad A, Burke MN, Brilakis ES. Megaly M, et al. Among authors: abbott jd. Cardiovasc Interv Ther. 2021 Oct;36(4):481-489. doi: 10.1007/s12928-020-00713-y. Epub 2020 Oct 10. Cardiovasc Interv Ther. 2021. PMID: 33037991
In patients with AMI, there was no statistical difference in the incidence of clinical and angiographic outcomes between AMI patients treated with DCB and DES. Larger studies with longer-term follow-up are needed to assess the clinical utility of DCBs in this setting....
In patients with AMI, there was no statistical difference in the incidence of clinical and angiographic outcomes between AMI patients treate …
Thirty-Day Readmissions After Carotid Artery Stenting Versus Endarterectomy: Analysis of the 2013-2014 Nationwide Readmissions Database.
Lima FV, Kolte D, Kennedy KF, Wang LJ, Abbott JD, Soukas PA, Aronow HD. Lima FV, et al. Among authors: abbott jd. Circ Cardiovasc Interv. 2020 Apr;13(4):e008508. doi: 10.1161/CIRCINTERVENTIONS.119.008508. Epub 2020 Mar 26. Circ Cardiovasc Interv. 2020. PMID: 32212834
Higher annual institutional CEA volumes were associated with lower risk for 30-day readmission; in contrast, institutional CAS volumes were not related to readmission risk. These data provide important insights into the short-term, outcomes of patients following carotid ar …
Higher annual institutional CEA volumes were associated with lower risk for 30-day readmission; in contrast, institutional CAS volumes were …
Incidence and Outcomes of Acute Coronary Syndrome After Transcatheter Aortic Valve Replacement.
Mentias A, Desai MY, Saad M, Horwitz PA, Rossen JD, Panaich S, Elbadawi A, Abbott JD, Sorajja P, Jneid H, Tuzcu EM, Kapadia S, Vaughan-Sarrazin M. Mentias A, et al. Among authors: abbott jd. JACC Cardiovasc Interv. 2020 Apr 27;13(8):938-950. doi: 10.1016/j.jcin.2019.11.027. Epub 2020 Feb 12. JACC Cardiovasc Interv. 2020. PMID: 32061612 Free PMC article.

On inverse probability weighting analysis, invasive approach was associated with lower adjusted long-term mortality (adjusted hazard ratio: 0.69; 95% confidence interval: 0.66 to 0.73; p < 0.01) and higher risk of repeat revascularization (adjusted hazard ratio: 1.29; 9

…
On inverse probability weighting analysis, invasive approach was associated with lower adjusted long-term mortality (adjusted hazard …
Temporal Trends and Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis.
Elbadawi A, Saad M, Elgendy IY, Barssoum K, Omer MA, Soliman A, Almahmoud MF, Ogunbayo GO, Mentias A, Gilani S, Jneid H, Aronow HD, Kleiman N, Abbott JD. Elbadawi A, et al. Among authors: abbott jd. JACC Cardiovasc Interv. 2019 Sep 23;12(18):1811-1822. doi: 10.1016/j.jcin.2019.06.037. JACC Cardiovasc Interv. 2019. PMID: 31537280 Free article.
TAVR for bicuspid AS was also associated with similar in-hospital mortality compared with tricuspid AS. Further studies are needed to evaluate long-term outcomes of TAVR for bicuspid AS....
TAVR for bicuspid AS was also associated with similar in-hospital mortality compared with tricuspid AS. Further studies are needed to evalua …
27 results